{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T06:16:41Z","timestamp":1770877001748,"version":"3.50.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>One of residual risks of coronary artery disease (CAD) occurrence and coronary plaque progression might be a triglyceride-glucose index (TyG index). Thus, this study aimed to investigate the impact of TyG index on coronary artery plaques detected by serial intravascular ultrasound (IVUS) in patients with CAD under low-density lipoprotein cholesterol (LDL-C) lowering therapy represented by statins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This observational cohort study included three clinical prospective trials (the ENTERPRISE trial, ESPECIAL-ACS study, and ZEUS trial) in which coronary plaques were assessed using serial grayscale IVUS at baseline and at 6\u201312 months follow-up. The patients were divided into two groups according to the cutoff value of baseline TyG index (dichotomized to \u2265 or &amp;lt;8.5) based on a previous report. The primary endpoint was defined as an absolute change in percentage atheroma volume (PAV) from baseline to follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 131 patients (mean age: 63 years; 92% men) completed the study and were analyzed. Compared to the low TyG index group, the high TyG index group had higher body mass index, triglyceride, and proportion of male, diabetes mellitus, and smoking history, as well as lower high-density lipoprotein cholesterol; whereas, there was no difference in LDL-C between both groups. The absolute change in PAV between the low TyG index group and high TyG index group only in patients who received aggressive lipid-lowering therapy (LLT) was \u22123.5\u00b11.4% by analysis of covariance (\n                      <jats:italic>p<\/jats:italic>\n                      =0.017). In addition, the baseline TyG index, male, and %change in LDL-C were significantly associated with the absolute change in PAV under aggressive LLT by multiple linear regression analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An elevated TyG index could be a residual risk of coronary plaque progression under aggressive LLT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1766778","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T05:23:02Z","timestamp":1770873782000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of TyG index on coronary plaques in patients with coronary artery disease under aggressive lipid-lowering therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Tatsuya","family":"Fukase","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotaka","family":"Dohi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwao","family":"Okai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine","place":["Tokyo, Japan"]},{"name":"Department of Radiological Technology, Faculty of Health Science, Juntendo University Graduate School","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine","place":["Tokyo, Japan"]},{"name":"Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the American College of cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/01.Cir.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"Jama"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5551\/jat.6551","article-title":"Plaque regression determined by intravascular ultrasound predicts long-term outcomes of patients with acute coronary syndrome","volume":"18","author":"Dohi","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.47391\/jpma.22-63","article-title":"Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance","volume":"72","author":"Ramdas Nayak","year":"2022","journal-title":"J Pak Med Assoc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40001-024-01728-4","article-title":"Association of triglyceride glucose index with cardiovascular events: insights from the Isfahan Cohort Study (ICS)","volume":"29","author":"Rafiee","year":"2024","journal-title":"Eur J Med Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12933-022-01620-7","article-title":"Incremental prognostic value of triglyceride glucose index additional to coronary artery calcium score in asymptomatic low-risk population","volume":"21","author":"Song","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12933-020-01210-5","article-title":"Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort","volume":"20","author":"Tian","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12933-022-01615-4","article-title":"Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1665292","article-title":"The triglyceride-glucose index is associated with coronary plaque features and clinical outcomes in patients with ST-segment elevation myocardial infarction","volume":"16","author":"Guo","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12933-021-01321-7","article-title":"Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study","volume":"20","author":"Zhao","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12933-025-02673-0","article-title":"The association between the triglyceride-glucose index and vulnerable plaques in patients with type 2 diabetes mellitus: insights from coronary computed tomography angiography","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5402.177","article-title":"Human experimentation. Code of ethics of the world medical association. Declaration of Helsinki","volume":"2","author":"Rickham","year":"1964","journal-title":"Br Med J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacasi.2024.08.014","article-title":"Effects of CPAP on atherosclerotic coronary plaques in patients with sleep-disordered breathing: the ENTERPRISE trial","volume":"4","author":"Fukase","year":"2024","journal-title":"JACC Asia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2016.08.011","article-title":"Effect of sitagliptin on plaque changes in coronary artery following acute coronary syndrome in diabetic patients: The ESPECIAL-ACS study","volume":"69","author":"Kuramitsu","year":"2017","journal-title":"J Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcme.2014.03.001","article-title":"Effect of combination of ezetimibe and a statin on coronary plaque regression in patients with acute coronary syndrome: ZEUS trial (eZEtimibe Ultrasound Study)","volume":"3","author":"Nakajima","year":"2014","journal-title":"IJC Metabol Endocr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5551\/jat.65908","article-title":"Lipid management for secondary prevention in atherosclerotic cardiovascular disease: A scoping review and scientific report","author":"Tanaka","year":"2025","journal-title":"J Atheroscler Thromb"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019)","volume":"42","author":"Umemura","year":"2019","journal-title":"Hypertens Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/01.gim.0000232480.00293.00","article-title":"Familial risk assessment for early-onset coronary heart disease","volume":"8","author":"Scheuner","year":"2006","journal-title":"Genet Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-025-02712-w","article-title":"Elevated triglyceride-glucose index is a risk factor for cardiovascular events in adults with type 1 diabetes: a cohort study","volume":"24","author":"Oh","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5551\/jat.61119","article-title":"High triglyceride-glucose index is associated with poor cardiovascular outcomes in nondiabetic patients with ACS with LDL-C below 1.8 mmol\/L","volume":"29","author":"Zhang","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"B26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40885-024-00274-9","article-title":"Prognostic value of the triglyceride-glucose index for adverse cardiovascular outcomes in young adult hypertension","volume":"30","author":"Li","year":"2024","journal-title":"Clin Hypertens"},{"key":"B27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12933-023-02018-9","article-title":"Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension","volume":"22","author":"Tao","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12944-023-01834-y","article-title":"Association between the insulin resistance marker TyG index and subsequent adverse long-term cardiovascular events in young and middle-aged US adults based on obesity status","volume":"22","author":"Chen","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(01)01175-5","article-title":"American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of cardiology task force on clinical expert consensus documents","volume":"37","author":"Mintz","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12928-019-00625-6","article-title":"Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics","volume":"35","author":"Saito","year":"2020","journal-title":"Cardiovasc Interv Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.118356","article-title":"Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices","volume":"55","author":"Contois","year":"2009","journal-title":"Clin Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12933-019-0862-9","article-title":"Myocardial mechano-energetic efficiency and insulin resistance in non-diabetic members of the Strong Heart Study cohort","volume":"18","author":"Mancusi","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2025.11.003","article-title":"Combined prognostic impact of diabetes, chronic kidney disease, and heart failure after acute myocardial infarction","author":"Yaginuma","year":"2025","journal-title":"J Cardiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-015-0615-4","article-title":"Emerging role of nitric oxide and heat shock proteins in insulin resistance","volume":"18","author":"Molina","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.01.071","article-title":"Impact of mitochondrial ROS production in the pathogenesis of insulin resistance","author":"Nishikawa","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0044-8","article-title":"Metabolites as regulators of insulin sensitivity and metabolism","volume":"19","author":"Yang","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1008","article-title":"Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin","volume":"59","author":"Gerrits","year":"2010","journal-title":"Diabetes"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2025.08.001","article-title":"Perivascular adipose tissue in cardiovascular disease: From mechanisms to therapeutic targets","volume":"87","author":"Ueda","year":"2026","journal-title":"J Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","article-title":"Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations","volume":"21","author":"Tao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-022-01593-7","article-title":"High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study","volume":"21","author":"Xu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9150(00)00601-8","article-title":"Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress","volume":"155","author":"Bae","year":"2001","journal-title":"Atherosclerosis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1865","article-title":"Factors contributing to increased platelet reactivity in people with diabetes","volume":"32","author":"Schneider","year":"2009","journal-title":"Diabetes Care"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2020.101172","article-title":"Triglyceride glucose index as a tool to motivate early lifestyle modification in young adults at diabetes risk: The Baependi Heart Study","volume":"20","author":"de Oliveira","year":"2020","journal-title":"Prev Med Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-023-06992-7","article-title":"Improvement of triglyceride-glucose index following bariatric surgery: a systematic review and meta-analysis","volume":"34","author":"Jamialahamdi","year":"2024","journal-title":"Obes Surg"},{"key":"B46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12933-023-01845-0","article-title":"Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes","volume":"22","author":"Denimal","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.23736\/s2724-6507.21.03465-5","article-title":"SGLT2 inhibitors improve plasma atherogenic biomarkers in patients with type 2 diabetes: a real-world retrospective observational study","volume":"48","author":"Imre","year":"2023","journal-title":"Minerva Endocrinol (Torino)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jacc.2015.05.065","article-title":"Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE-IVUS trial","volume":"66","author":"Tsujita","year":"2015","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1766778\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T05:23:03Z","timestamp":1770873783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1766778\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":48,"alternative-id":["10.3389\/fendo.2026.1766778"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1766778","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"article-number":"1766778"}}